STRS Ohio’s Kura Oncology KURA Stock Holding History

STRS Ohio’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	+10,900	New	+$103K	﹤0.01%	1811
2026 Q1	–	Sell	-19,200	Closed	-$199K	–	2187
2025 Q4	$199K	Hold	19,200	–	–	﹤0.01%	1519
2025 Q3	$170K	Hold	19,200	–	–	﹤0.01%	1620
2025 Q2	$111K	Sell	19,200 -2,500	-12%	-$15.3K	﹤0.01%	1833
2025 Q1	$143K	Hold	21,700	–	–	﹤0.01%	1583
2024 Q4	$189K	Hold	21,700	–	–	﹤0.01%	1524
2024 Q3	$424K	Hold	21,700	–	–	﹤0.01%	1329
2024 Q2	$447K	Buy	21,700 +20,500	+1,708%	+$421K	﹤0.01%	1306
2024 Q1	$25K	Buy	+1,200	New	+$23.3K	﹤0.01%	1835
2021 Q2	–	Sell	-3,100	Closed	-$87K	–	2334
2021 Q1	$87K	Sell	3,100 -16,600	-84%	-$525K	﹤0.01%	1968
2020 Q4	$643K	Buy	+19,700	New	+$692K	﹤0.01%	1339
2018 Q3	–	Sell	-4,200	Closed	-$80.5K	–	2145
2018 Q2	$76K	Hold	4,200	–	–	﹤0.01%	1908
2018 Q1	$78K	Hold	4,200	–	–	﹤0.01%	1665
2017 Q4	$64K	Hold	4,200	–	–	﹤0.01%	1702
2017 Q3	$62K	Hold	4,200	–	–	﹤0.01%	1740
2017 Q2	$39K	Buy	+4,200	New	+$38.2K	﹤0.01%	1829

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

STRS Ohio's KURA Position: Q2 2026 in Review

STRS Ohio opened a new position in Kura Oncology (KURA) in Q2 2026: 10,900 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #1811 among its holdings. This is a return to the name: STRS Ohio previously reported a position in KURA as recently as Q4 2025.

STRS Ohio first reported a position in KURA in Q2 2017 and has held it in 16 quarters since. The position peaked at $643K in Q4 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

STRS Ohio held 10,900 shares of Kura Oncology worth $120K as of Q2 2026.
Kura Oncology was a new STRS Ohio position in Q2 2026.
Kura Oncology made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1811 holding.
STRS Ohio first reported a position in Kura Oncology in Q2 2017 and has held it in 16 quarters since.
STRS Ohio's Kura Oncology position peaked at $643K in Q4 2020.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.